Van Ham P[au] - Search Results

Year	Number of Results
1974	1
1978	1
1995	7
1996	3
1997	4
1998	3
1999	3
2002	1
2004	2
2005	2
2006	2
2007	1
2008	1
2011	3
2012	1
2013	2
2014	3
2015	4
2016	2
2017	2
2018	1
2020	1
2022	0

1

Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.

Connell BJ, Hermans LE, Wensing AMJ, Schellens I, Schipper PJ, van Ham PM, de Jong DTCM, Otto S, Mathe T, Moraba R, Borghans JAM, Papathanasopoulos MA, Kruize Z, Venter FWD, Kootstra NA, Tempelman H, Tesselaar K, Nijhuis M. Connell BJ, et al. Among authors: van ham pm. Sci Rep. 2020 Sep 28;10(1):15866. doi: 10.1038/s41598-020-71699-z. Sci Rep. 2020. PMID: 32985522 Free PMC article.

2

Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration.

Decaestecker C, Debeir O, Van Ham P, Kiss R. Decaestecker C, et al. Among authors: van ham p. Med Res Rev. 2007 Mar;27(2):149-76. doi: 10.1002/med.20078. Med Res Rev. 2007. PMID: 16888756 Review.

3

CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.

van Diemen FR, Kruse EM, Hooykaas MJ, Bruggeling CE, Schürch AC, van Ham PM, Imhof SM, Nijhuis M, Wiertz EJ, Lebbink RJ. van Diemen FR, et al. Among authors: van ham pm. PLoS Pathog. 2016 Jun 30;12(6):e1005701. doi: 10.1371/journal.ppat.1005701. eCollection 2016 Jun. PLoS Pathog. 2016. PMID: 27362483 Free PMC article.

4

Primary resistance to integrase strand-transfer inhibitors in Europe.

Casadellà M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, Garcia F, Struck D, Alexiev I, Bakken Kran AM, Hoepelman AI, Kostrikis LG, Somogyi S, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Staneková D, Stanojevic M, Van Laethem K, Zidovec Lepej S, Clotet B, Boucher CA, Paredes R, Wensing AM; SPREAD programme. Casadellà M, et al. Among authors: van ham pm. J Antimicrob Chemother. 2015 Oct;70(10):2885-8. doi: 10.1093/jac/dkv202. Epub 2015 Jul 17. J Antimicrob Chemother. 2015. PMID: 26188038

5

A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.

Lebbink RJ, de Jong DC, Wolters F, Kruse EM, van Ham PM, Wiertz EJ, Nijhuis M. Lebbink RJ, et al. Among authors: van ham pm. Sci Rep. 2017 Feb 8;7:41968. doi: 10.1038/srep41968. Sci Rep. 2017. PMID: 28176813 Free PMC article.

6

The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor-Resistant Clinical Isolates.

Ray N, Li T, Lin Z, Protack T, van Ham PM, Hwang C, Krystal M, Nijhuis M, Lataillade M, Dicker I. Ray N, et al. Among authors: van ham pm. J Acquir Immune Defic Syndr. 2017 May 1;75(1):52-60. doi: 10.1097/QAI.0000000000001304. J Acquir Immune Defic Syndr. 2017. PMID: 28234686 Free PMC article.

7

Complex T-cell receptor repertoire dynamics underlie the CD8+ T-cell response to HIV-1.

Costa AI, Koning D, Ladell K, McLaren JE, Grady BP, Schellens IM, van Ham P, Nijhuis M, Borghans JA, Keşmir C, Price DA, van Baarle D. Costa AI, et al. Among authors: van ham p. J Virol. 2015 Jan;89(1):110-9. doi: 10.1128/JVI.01765-14. Epub 2014 Oct 15. J Virol. 2015. PMID: 25320304 Free PMC article.

8

Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms.

Bosman KJ, Wensing AM, Pijning AE, van Snippenberg WJ, van Ham PM, de Jong DM, Hoepelman AI, Nijhuis M. Bosman KJ, et al. Among authors: van ham pm. J Int AIDS Soc. 2018 Sep;21(9):e25185. doi: 10.1002/jia2.25185. J Int AIDS Soc. 2018. PMID: 30375818 Free PMC article.

9

Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients.

van Lelyveld SF, Symons J, van Ham P, Connell BJ, Nijhuis M, Wensing AM, Hoepelman AI. van Lelyveld SF, et al. Among authors: van ham p. Int J Antimicrob Agents. 2016 Jan;47(1):84-90. doi: 10.1016/j.ijantimicag.2015.09.013. Epub 2015 Oct 25. Int J Antimicrob Agents. 2016. PMID: 26585497

10

Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient.

Symons J, Vandekerckhove L, Hütter G, Wensing AM, van Ham PM, Deeks SG, Nijhuis M. Symons J, et al. Among authors: van ham pm. Clin Infect Dis. 2014 Aug 15;59(4):596-600. doi: 10.1093/cid/ciu284. Epub 2014 Apr 23. Clin Infect Dis. 2014. PMID: 24759824 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results